Tag: bioAffinity Technologies

bioAffinity Technologies Announces Closing of $2.6 Million Registered Direct Offering & Concurrent Private Placement

bioAffinity Technologies Announces Closing of $2.6 Million Registered Direct Offering & Concurrent Private Placement

October 21, 2024 10:45 AM Eastern Daylight Time SAN ANTONIO–(BUSINESS WIRE)–bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer, today announced it has closed…

Read More Read More

bioAffinity Technologies has filed a notice of an exempt offering of securities to raise $1,302,084.00 in New Equity Investment.

bioAffinity Technologies has filed a notice of an exempt offering of securities to raise $1,302,084.00 in New Equity Investment.

According to filings with the U.S. Securities and Exchange Commission, bioAffinity Technologies is raising up to $1,302,084.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Maria Zannes…

Read More Read More